Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
4.000
0.00 (0.00%)
At close: Aug 26, 2025, 4:00 PM
3.960
-0.040 (-1.00%)
After-hours: Aug 26, 2025, 4:00 PM EDT

Kezar Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
--7---
Upgrade
Cost of Revenue
54.0465.7485.751.0138.94-
Upgrade
Gross Profit
-54.04-65.74-78.7-51.01-38.94-
Upgrade
Selling, General & Admin
21.7223.3926.5420.1515.7211.97
Upgrade
Research & Development
-----30.98
Upgrade
Operating Expenses
21.7223.3926.5420.1515.7242.95
Upgrade
Operating Income
-75.75-89.14-105.24-71.16-54.66-42.95
Upgrade
Interest Expense
-1.44-1.59-1.55-1.19-0.16-
Upgrade
Interest & Investment Income
6.398.4611.14.110.191.21
Upgrade
EBT Excluding Unusual Items
-70.8-82.27-95.68-68.24-54.63-41.74
Upgrade
Merger & Restructuring Charges
0.01-1.47-6.19---
Upgrade
Pretax Income
-70.79-83.74-101.87-68.24-54.63-41.74
Upgrade
Net Income
-70.79-83.74-101.87-68.24-54.63-41.74
Upgrade
Net Income to Common
-70.79-83.74-101.87-68.24-54.63-41.74
Upgrade
Shares Outstanding (Basic)
777754
Upgrade
Shares Outstanding (Diluted)
777754
Upgrade
Shares Change (YoY)
0.36%0.48%7.70%27.69%19.90%130.58%
Upgrade
EPS (Basic)
-9.69-11.49-14.04-10.13-10.35-9.49
Upgrade
EPS (Diluted)
-9.69-11.49-14.04-10.13-10.35-9.49
Upgrade
Free Cash Flow
-64.34-74.24-83.46-60.42-42.75-37.14
Upgrade
Free Cash Flow Per Share
-8.81-10.18-11.50-8.97-8.10-8.44
Upgrade
Operating Margin
---1503.39%---
Upgrade
Profit Margin
---1455.29%---
Upgrade
Free Cash Flow Margin
---1192.21%---
Upgrade
EBITDA
-74.74-88.1-104.17-70.14-53.15-41.41
Upgrade
D&A For EBITDA
1.011.041.071.021.511.54
Upgrade
EBIT
-75.75-89.14-105.24-71.16-54.66-42.95
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q